Edun, Pate & seven ministers Tinubu needs to revamp Nigeria, by Lolade Akinmurele Post author:thepodiumadmin Post published:August 22, 2023 Post category:Opinion/News Analysis Post comments:0 Comments … Continue ReadingEdun, Pate & seven ministers Tinubu needs to revamp Nigeria, by Lolade Akinmurele
Ejiroghene Udu, ‘The Generator Girl’, defying stereotypes in the power sector Post author:thepodiumadmin Post published:August 21, 2023 Post category:News Analysis/Executive Profiles Post comments:0 Comments … Continue ReadingEjiroghene Udu, ‘The Generator Girl’, defying stereotypes in the power sector
The blue economy and what it means for Nigerians Post author:thepodiumadmin Post published:August 21, 2023 Post category:Opinion/News Analysis Post comments:0 Comments … Continue ReadingThe blue economy and what it means for Nigerians
Telecom poses the biggest test for Bosun Tijani Post author:thepodiumadmin Post published:August 17, 2023 Post category:News Analysis Post comments:0 Comments … Continue ReadingTelecom poses the biggest test for Bosun Tijani
I have served small businesses for more than 10 years — Here are three investments to consider that will help you succeed Post author:thepodiumadmin Post published:August 15, 2023 Post category:News Analysis/Opinion Post comments:0 Comments … Continue ReadingI have served small businesses for more than 10 years — Here are three investments to consider that will help you succeed
Tamunominini Olufunke Makinde: Being Oyo First Lady hasn’t changed my personality Post author:thepodiumadmin Post published:August 13, 2023 Post category:Opinion/News Analysis Post comments:0 Comments … Continue ReadingTamunominini Olufunke Makinde: Being Oyo First Lady hasn’t changed my personality
Making the new tax regime work Post author:thepodiumadmin Post published:August 11, 2023 Post category:News Analysis/Opinion Post comments:0 Comments … Continue ReadingMaking the new tax regime work
From Ribena to Panadol: What GSK’s gradual exit means Post author:thepodiumadmin Post published:August 7, 2023 Post category:News Analysis Post comments:0 Comments … Continue ReadingFrom Ribena to Panadol: What GSK’s gradual exit means